Principal Software Engineer

Werfen and Oxford Nanopore collaborate to enhance transplant testing. Werfen and Oxford Nanopore Technologies have expanded their collaboration to validate Werfen's transplant assays on Oxford Nanopore's sequencing platforms, aiming to deliver faster, more accurate donor-recipient matching. May 29, 2026 Werfen announced a strategic collaboration with Oxford Nanopore Technologies to validate Werfen's specialized transplant assay portfolios for use on Oxford Nanopore's sequencing platforms. Building on a collaboration between Werfen and Oxford Nanopore that began in 2020, this marks a significant milestone, combining Werfen's validated, high-precision transplant assays with Oxford Nanopore's rapid, information-rich sequencing technology. Together, the companies aim to streamline laboratory workflows, providing a fast and accurate "DNA-to-result" experience that leverages the speed and scalability of nanopore sequencing. By ensuring the optimization and compatibility of Werfen's transplant portfolio, including solutions for Human Leukocyte Antigen (HLA) typing and pre-transplant matching, with Oxford Nanopore's platforms, the aim is to enable laboratories to implement high-quality testing with reduced complexity and faster results. This is particularly critical in transplantation, where rapid, high-resolution data is essential for donor-recipient matching and long-term success.

AcouSort receives prepayment of royalties. AcouSort AB today announced the signing of an amendment to its license and distribution agreement with the leading blood-gas analyzer company, Werfen. Under the amendment, Werfen will prepay minimum royalties for 2027 and 2028. Together with Werfen's regular 2026 minimum royalty, the total sum payable to AcouSort in early 2026 amounts to approximately USD 1.3 million. "Based on our current cash position and this prepayment together with Werfen's regular 2026 minimum royalties alone will fund AcouSort into 2027," said AcouSort's CEO Dr. Torsten Freltoft. The original agreement was signed in spring 2018. Using AcouSort acoustofluidic background technology, the parties jointly developed the solution now implemented in Werfen's groundbreaking GEM Premier 7000 system for point-of-care blood gas analysis. The hemolysis detection in GEM Premier 7000 is based upon patented acoustofluidic technology for plasma separation, combined with photometric determination. In just 45 seconds, the GEM Premier 7000 detects hemolysis, while delivering a complete menu of blood-gas results (pH, pO2, pO2, sodium, potassium, ionized calcium, chloride, glucose, lactate, hematocrit, total hemoglobin, total bilirubin and CO-Oximetry). No other terms of the License and Distribution Agreement with Werfen have been changed. In terms of liquidity, the change takes effect within Q1, while revenue recognition occurs according to applicable accounting principles. This information is information that AcouSort is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-03-10 17:30 CET. FOR FURTHER INFORMATION ABOUT ACOUSORT, PLEASE CONTACT: Torsten Freltoft, CEO Telephone: +45 2045 0854 E-mail:[email protected] ABOUT ACOUSORT AcouSort AB (corporate registration number 556824-1037) is an innovative technology company focusing on developing products and solutions for integrated preparation of biological samples. With the help of sound waves, the company's products can separate blood cells, concentrate, purify, and stain cells, exosomes, and bacteria from biological samples. The technology of the company's products is acoustofluidics, where sound waves and microfluidics enable automated handling of samples in a range of application areas, from research on new biomarkers to the development of new diagnostic systems for near-patient testing - so-called Point-of Care (POC) systems. The company's commercialization strategy is based on the already proven business model of providing separation modules to diagnostic system manufacturers for integrated sample preparation as well as to continue the commercialization of the company's research instruments. With the help of the company's products and development of point-of-care tests, new diagnostic systems and treatments are enabled, addressing some of the most challenging disease areas of our time: cancer, infectious diseases, and cardiovascular diseases. AcouSort is listed at Nasdaq First North Growth Market. The company's Certified Adviser is Tapper Partners AB. Attachments AcouSort receives prepayment of royalties

Biological sciences manufacturing job at Werfen North America | Apply now. Manufacturing Associate role at Werfen North America. Werfen North America is hiring for a Manufacturing Associate 1 position in San Diego, CA. This manufacturing job offers an opportunity to work in a regulated life sciences environment, supporting the production of advanced autoimmune diagnostic products used by clinicians worldwide. The Manufacturing Associate role is ideal for candidates seeking hands-on experience in diagnostic kit manufacturing while working with automated equipment and quality-driven processes. Job details: * Job Title: Manufacturing Associate 1 * Location: San Diego, California * Industry: Life Sciences / Diagnostics Manufacturing * Employment Type: Full-time * Department: Autoimmunity Manufacturing * Salary Range: $25/hr to $30/hr * Team: QUANTA Flash and Aptiva Manufacturing Team About Werfen North America: Werfen North America is a global leader in specialized diagnostics, focusing on autoimmune, hemostasis, acute care, and transfusion medicine. The company is committed to delivering high-quality diagnostic solutions that help healthcare professionals improve patient outcomes. Werfen North America operates under strict quality systems and regulatory standards, ensuring innovation, safety, and reliability across all manufacturing processes. Apply for more similar Manufacturing job offers in the USA. Educational requirements: * Bachelor's degree in biological or related sciences is required * Certificate program or Associate's degree with 3 - 4 years of relevant life sciences laboratory experience may be substituted * Relevant work experience may be considered in place of formal education at management's discretion Key responsibilities for Manufacturing Associate role: * Follow standard operating procedures and work instructions under supervision * Manufacture and test in-process components and diagnostic reagents * Participate in bulking and evaluation of reagents and components * Operate, clean, and maintain manufacturing equipment and instrumentation * Package and fill components according to manufacturing procedures * Maintain accurate Device History Records and related documentation * Assist with evaluation of raw materials when required * Ensure compliance with ISO, FDA, and Quality Management System regulations * Maintain a clean, safe, and organized lab and work environment * Reflect Werfen values in daily work and team interactions Skills required for Manufacturing Associate role: * Basic knowledge of laboratory practices and procedures * Understanding of Good Manufacturing Practices (GMP) * Strong attention to detail and quality standards * Ability to identify product defects or equipment issues * Problem-solving and troubleshooting skills * Effective time management skills * Ability to work collaboratively in a team environment * Willingness to learn and adapt in a regulated manufacturing setting Benefits of the Manufacturing Associate role: * Competitive hourly pay ranging from $25 to $30 per hour * Medical, dental, and vision insurance coverage * 401(k) retirement plan with employer match * Paid vacation and sick leave * Opportunity to work in a highly specialized diagnostic manufacturing environment * Career growth opportunities within Werfen North America